Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| XOMA Corp. | 9 | 0 | 1 | 0 | €24.40 | €68.62 | 181.230% |
| Galmed Pharmaceuticals Ltd. | 13 | 0 | 0 | 0 | €6.40 | €68.81 | 975.078% |
| Dr. Reddy's Laboratories Ltd. ADR | 7 | 1 | 0 | 0 | €71.50 | €75.37 | 5.413% |
| Exact Sciences | 20 | 0 | 4 | 0 | €61.48 | €75.89 | 23.440% |
| Incyte Corp. | 14 | 2 | 2 | 0 | €60.88 | €76.76 | 26.087% |
| Insmed Inc. | 46 | 0 | 2 | 0 | €64.50 | €76.89 | 19.202% |
| Cytokinetics Inc. | 37 | 1 | 5 | 0 | €50.50 | €82.73 | 63.814% |
| Ultragenyx Pharmaceutical Inc. | 29 | 1 | 5 | 0 | €49.00 | €82.93 | 69.247% |
| Intra-Cellular Therapies Inc. | 36 | 0 | 5 | 0 | €65.00 | €85.14 | 30.989% |
| Gilead Sciences Inc | 11 | 0 | 1 | 0 | €77.27 | €85.74 | 10.957% |
| Axsome Therapeutics Inc | 1 | 0 | 0 | 0 | €80.60 | €100.00 | 24.069% |
| Sanofi S.A. | 4 | 0 | 0 | 0 | €101.40 | €109.00 | 7.495% |
| Ipsen S.A. | 1 | 0 | 0 | 0 | €114.00 | €109.00 | -4.386% |
| Viking Therapeutics Inc | 6 | 0 | 2 | 0 | €57.74 | €110.00 | 90.509% |
| Novartis AG ADR | 4 | 0 | 1 | 0 | €103.50 | €112.40 | 8.597% |
| Abbott Laboratories | 22 | 0 | 3 | 0 | €102.48 | €116.48 | 13.661% |
| Merck & Co. Inc. | 32 | 1 | 2 | 0 | €99.90 | €126.38 | 26.507% |
| Novo Nordisk A/S ADR | 25 | 1 | 4 | 0 | €104.50 | €144.48 | 38.258% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €127.00 | €150.00 | 18.110% |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €140.65 | €165.00 | 17.312% |
| Merck KGaA | 8 | 1 | 4 | 0 | €155.95 | €172.00 | 10.292% |
| AbbVie Inc. | 33 | 0 | 0 | 0 | €177.06 | €181.45 | 2.478% |
| Jazz Pharmaceuticals plc | 33 | 0 | 3 | 0 | €98.22 | €182.69 | 86.000% |
| Repligen Corp. | 15 | 0 | 1 | 0 | €131.60 | €183.52 | 39.450% |
| Krystal Biotech | 19 | 0 | 1 | 0 | €160.75 | €184.02 | 14.476% |